Beáta Dérfalvi

2.3k total citations
37 papers, 644 citations indexed

About

Beáta Dérfalvi is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Beáta Dérfalvi has authored 37 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Hematology and 11 papers in Genetics. Recurrent topics in Beáta Dérfalvi's work include Immunodeficiency and Autoimmune Disorders (13 papers), Immune Cell Function and Interaction (10 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Beáta Dérfalvi is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (13 papers), Immune Cell Function and Interaction (10 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Beáta Dérfalvi collaborates with scholars based in Canada, Hungary and United States. Beáta Dérfalvi's co-authors include András Falus, Antónia Szántó, Attila J. Szabó, Tünde Tarr, N. Györi, G. Szegedi, Margit Zeher, László Maródi, Edit I. Buzás and Lilla Turiák and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Beáta Dérfalvi

35 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beáta Dérfalvi Canada 14 271 193 144 140 105 37 644
Hisako Inoue Japan 17 275 1.0× 230 1.2× 184 1.3× 194 1.4× 41 0.4× 42 834
Piero Farruggia Italy 20 222 0.8× 234 1.2× 69 0.5× 207 1.5× 289 2.8× 62 889
Safa Barış Türkiye 17 512 1.9× 199 1.0× 72 0.5× 108 0.8× 236 2.2× 87 951
Markus Zeisbrich Germany 12 289 1.1× 150 0.8× 134 0.9× 131 0.9× 28 0.3× 16 663
Mildred Wilson United States 7 712 2.6× 222 1.2× 216 1.5× 135 1.0× 70 0.7× 7 1.0k
Katarzyna Romanowska‐Próchnicka Poland 14 230 0.8× 142 0.7× 186 1.3× 77 0.6× 30 0.3× 37 644
Alessandra Cannizzaro Italy 11 396 1.5× 127 0.7× 365 2.5× 161 1.1× 70 0.7× 17 729
Dina Attias Israel 16 210 0.8× 169 0.9× 67 0.5× 205 1.5× 61 0.6× 46 864
Nozomi Iwanaga Japan 12 181 0.7× 158 0.8× 238 1.7× 67 0.5× 33 0.3× 47 611

Countries citing papers authored by Beáta Dérfalvi

Since Specialization
Citations

This map shows the geographic impact of Beáta Dérfalvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beáta Dérfalvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beáta Dérfalvi more than expected).

Fields of papers citing papers by Beáta Dérfalvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beáta Dérfalvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beáta Dérfalvi. The network helps show where Beáta Dérfalvi may publish in the future.

Co-authorship network of co-authors of Beáta Dérfalvi

This figure shows the co-authorship network connecting the top 25 collaborators of Beáta Dérfalvi. A scholar is included among the top collaborators of Beáta Dérfalvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beáta Dérfalvi. Beáta Dérfalvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upton, Julia, et al.. (2025). Inborn errors of immunity (primary immunodeficiencies). Allergy Asthma and Clinical Immunology. 20(S3). 76–76. 1 indexed citations
2.
Nazarali, Samir, Beáta Dérfalvi, & Paul A. Clark. (2025). Late presentation of X-linked inhibitor of apoptosis (XIAP) deficiency in a young adult. Allergy Asthma and Clinical Immunology. 21(1). 19–19.
3.
Grunebaum, Eyal, Sneha Suresh, Bruce Ritchie, et al.. (2024). 3 Development of the Canadian Inborn Errors of Immunity National Registry (CIEINR). Clinical Immunology. 262. 109945–109945. 1 indexed citations
4.
Dérfalvi, Beáta, et al.. (2023). MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes. Pediatric Rheumatology. 21(1). 53–53. 2 indexed citations
5.
Ramsey, Suzanne, Elizabeth Stringer, Bianca Lang, et al.. (2022). Differentially Expressed Inflammation-Regulating MicroRNAs in Oligoarticular Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 50(2). 227–235. 4 indexed citations
6.
Parsons, Brendon, Andrew P. Makrigiannis, Nicolas Pichaud, et al.. (2022). Modulation of the cell membrane lipid milieu by peroxisomal β-oxidation induces Rho1 signaling to trigger inflammatory responses. Cell Reports. 38(9). 110433–110433. 15 indexed citations
7.
Leek, Timothy K. Vander, Edmond S. Chan, Lori Connors, et al.. (2021). COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI). Allergy Asthma and Clinical Immunology. 17(1). 29–29. 23 indexed citations
8.
Käsermann, Fabian, et al.. (2021). High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation. Frontiers in Immunology. 12. 660506–660506. 15 indexed citations
9.
10.
Orbán, I, Tamás Constantin, Beáta Dérfalvi, et al.. (2018). The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatology International. 38(S1). 243–250. 1 indexed citations
11.
Dérfalvi, Beáta, Kelly Maurer, Donna M. McDonald‐McGinn, et al.. (2015). B cell development in chromosome 22q11.2 deletion syndrome. Clinical Immunology. 163. 1–9. 24 indexed citations
12.
Issekutz, Andrew C., et al.. (2015). Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G. Clinical Immunology. 161(2). 373–383. 6 indexed citations
13.
Kovács, Gábor, et al.. (2013). Rheumatic symptoms in childhood leukaemia and lymphoma-a ten-year retrospective study. Pediatric Rheumatology. 11(1). 20–20. 25 indexed citations
14.
György, Bence, Tamás Szabó, Lilla Turiák, et al.. (2012). Improved Flow Cytometric Assessment Reveals Distinct Microvesicle (Cell-Derived Microparticle) Signatures in Joint Diseases. PLoS ONE. 7(11). e49726–e49726. 121 indexed citations
15.
Jiao, Hong, Beáta Tóth, Melinda Erdös, et al.. (2008). Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Molecular Immunology. 46(1). 202–206. 53 indexed citations
16.
Erdös, Melinda, Gabriella Lakos, Beáta Dérfalvi, et al.. (2007). Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome. Molecular Immunology. 45(1). 278–282. 7 indexed citations
17.
18.
Dérfalvi, Beáta, Péter Igaz, András Fülöp, Csaba Szalai, & András Falus. (2000). INTERLEUKIN‐6‐INDUCED PRODUCTION OF TYPE II ACUTE PHASE PROTEINS AND EXPRESSION OF junB GENE ARE DOWNREGULATED BY HUMAN RECOMBINANT GROWTH HORMONE IN VITRO. Cell Biology International. 24(2). 109–114. 16 indexed citations
19.
Dérfalvi, Beáta. (1998). In vitro effect of human recombinant growth hormone on lymphocyte and granulocyte function of healthy and uremic children. Immunology Letters. 63(1). 41–47. 6 indexed citations
20.
Dérfalvi, Beáta, Csaba Szalai, Yvette Mándi, András Király, & András Falus. (1998). GROWTH HORMONE RECEPTOR GENE EXPRESSION ON HUMAN LYMPHOCYTIC AND MONOCYTIC CELL LINES. Cell Biology International. 22(11-12). 849–853. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisako Inoue Breakdown of academic impact, for papers by Piero Farruggia Breakdown of academic impact, for papers by Safa Barış Breakdown of academic impact, for papers by Markus Zeisbrich Breakdown of academic impact, for papers by Mildred Wilson Breakdown of academic impact, for papers by Katarzyna Romanowska‐Próchnicka Breakdown of academic impact, for papers by Alessandra Cannizzaro Breakdown of academic impact, for papers by Dina Attias Breakdown of academic impact, for papers by Nozomi Iwanaga
Rankless by CCL
2026